Drinking water contaminants, gene polymorphisms, and fetal growth.

There are still many uncertainties regarding the risk of adverse pregnancy outcomes associated with exposure to drinking water disinfection by-products. In Montreal, Quebec, Canada, we carried out a hospital-based case-control study including 493 cases of intrauterine growth restriction defined as birth weight below the 10th percentile for gestational age and sex, according to Canadian standards. Controls were babies (n = 472) delivered at the same hospital whose birth weight was at or above the 10th percentile, matched for gestational age, race, and sex. Exposure to total and specific trihalomethanes was measured using regulatory data collected by municipalities and the provincial Ministry of Environment. Residential history, water drinking, and shower habits during pregnancy, as well as known risk factors for intrauterine growth restriction, were measured with a face-to-face interview with all mothers. Mothers and newborns were characterized for two genetic polymorphisms, one in the CYP2E1 gene (G1259C), and another in the 5,10-methylenetetrahydrofolate reductase (MTHFR) gene (C677T). Exposure to specific and total trihalomethanes from drinking water, determined for 458 cases and 426 controls, did not result in an increased risk of intrauterine growth restriction. However, significant effect modification was observed between newborns with and without the CYP2E1 variant; among newborns with the variant, the adjusted odds ratio for intrauterine growth restriction associated with exposure to average total trihalomethanes above the 90th percentile (corresponding to 29.4 [micro]g/L) was 13.20 (95% confidence interval, 1.19-146.72). These findings suggest that exposure to trihalomethanes at the highest levels can affect fetal growth but only in genetically susceptible newborns. Key words: CYP2E1 gene, disinfection by-products, drinking water, gene polymorphism, gene-environment interaction, intrauterine growth restriction, low birth weight, MTHFR gene, trihalomethanes. Environ Health Perspect 112:1213-1216 (2004). doi:10.1289/ehp.7003 available via http://dx.doi.org/[Online 26 May 2004]

**********

Chlorination by-products in drinking water come from the reaction of chlorine with organic material in the water. This reaction occurs naturally or originates from municipal, agricultural, and industrial wastes. Trihalomethanes (THMs) such as chloroform, bromoform, bromodichloromethane (BDCM), and chlorodibromomethane are the most prevalent class of disinfection by-products (DBPs) found in treated water. From the toxicologic literature, chloroform appears to affect fetal development (Geveker Graves et al. 2001), by mechanisms that have not yet been elucidated. In the last decade, a number of epidemiologic studies have been carried out to determine the effect of DBPs on adverse pregnancy outcomes (Bove et al. 2002). Two recent reviews propose that the weight of the evidence, although moderate and not fully conclusive, is in favor of an association between DBPs and fetal growth restriction (Bove et al. 2002; Geveker Graves et al. 2001). Most of the previous studies were based on information from birth records, and despite the fact that the number of records included was usually large, the information that was available on other risk factors for fetal growth, or on other personal variables influencing exposure to DBPs, was often limited.

The primary enzyme involved in the metabolism of low doses of chloroform is CYP2E1 (Meek et al. 2002). My group has previously shown that a polymorphism in the CYP2E1 gene can modify the effect of water contaminants (Infante-Rivard et al. 2002a). Another enzyme, 5,10-methylenetetrahydrofolate reductase (MTHFR), together with folic acid, is involved in the remethylation of homocysteine to methionine, as well as in the methylation of DNA, proteins, and phospholipids (Botto and Yang 2000). Alston (1991) reported that vitamin [B.sub.12]-dependent methionine biosynthesis could be inhibited by chloroform. Common polymorphisms in the MTHFR gene have been identified (Botto and Yang 2000). To my knowledge, no study has considered the role of genetic polymorphisms on the relationship between DBPs and fetal growth.

My group carried out a study on genetic and metabolic risk factors for intrauterine growth restriction (IUGR) (Infante-Rivard et al. 2002b, 2003a, 2003b). In the course of the study, we also collected personal and environmental information to analyze the association between chemical water contaminants and fetal growth.

Materials and Methods

Study subjects. Details on study subjects have been reported elsewhere (Infante-Rivard et al. 2002b). Briefly, cases were newborns whose birth weight was below the 10th percentile for gestational age and sex, based on Canadian standards (Arbuckle et al. 1993). All cases seen at the largest university-based mother-child center in Montreal between May 1998 and June 2000 who were born singleton, alive after the 24th week of gestation, and without severe congenital anomalies were eligible for the study. During that period, 505 newborns met the eligibility criteria, and 493 were included in the study (97.6%). Controls were born at the same hospital and met the same eligibility criteria, except that their birth weight was at or above the 10th percentile. They were matched to cases for gestational week, sex, and race (white, black, Hispanic/Amerindian, and Asian) and usually born within 1 week of the matched case subject. Of those identified, 480 controls were invited to participate, and 472 accepted (98.3%). The project was approved by the hospital ethics committee. An informed consent was signed by the mother to collect cord and maternal blood.

Interview. A face-to-face interview with all mothers of cases and controls was carried out in French or English at the hospital, generally within 2 days of delivery. It included questions about demographic factors, complications of pregnancy, maternal chronic diseases, obstetric history, and smoking. The medical record was used for variables such as height and weight and to confirm pregnancy diseases. To determine exposure to water contaminants for each pregnancy trimester until delivery, we collected the following information: maternal residential history, source of drinking water (community, private well, bottled), use and type of domestic water filter, average number of glasses of water per day at home or elsewhere (including those with reconstituted frozen fruit juices), usual way of consuming tap water (directly from tap, after refrigeration), average number of showers per week, and usual duration of showers.

Exposure ascertainment. For the study period, exposure to THMs from drinking water according to place of residence was obtained from regulatory data collected by municipalities and the Ministry of Environment. There were 189 distribution systems involved; although for most systems there were multiple measurements on the same date, I was only provided with average measures. Of the 965 women in the study, 10 lived in other Canadian provinces, 37 lived in other countries, and there was no address for 2 others, leaving 916 study women reporting addresses in the province. Overall, THM information was available for 884 (91.6%) of the study women (458 cases and 426 controls).

Exposure from drinking water. Estimates of exposure levels to total and specific THMs from drinking water were tabulated first as average level at the tap (from treatment plant data) over the pregnancy period [(sum of concentration i x duration in days at level i based on residence) / (total number of pregnancy days)]; this measure was then categorized at the 90th percentile of the distribution for cases and controls. Another index was the cumulative level over the pregnancy period (sum of concentration i x duration in days at level i); it was also categorized at the 90th percentile of the distribution. When the source of drinking water was exclusively well water or bottled water, the exposure levels for drinking water were set at zero. Finally, the estimated average level of THMs at the tap from the municipal distribution system was multiplied by the number of glasses of tap water per day averaged over pregnancy. Another version of this index included applying an arbitrary weight of 0.9 to the average number of tap water glasses if a filter was used or if the water was refrigerated before consumption.

Exposure from showering. Exposure to THMs from showering was set to zero for residences using exclusively well water, others were assigned their network level. An index of exposure to THMs from showering was defined as frequency of showers per week (times duration) multiplied by the average levels of exposure to THMs at the tap from the distributing network.

Genotyping. Polymerase chain reaction (PCR) allele-specific oligonucleotide hybridization assays have been used to genotype the polymorphism G1259C (a G-to-C substitution at position 1259 in the promoter) that defines the allele CYP2E1 *5 (Infante-Rivard et al. 2002a) as well as the MTHFR C677T polymorphism (Infante-Rivard et al. 2002b).

Statistical analysis. Out of 493 cases and 472 controls, 451 were matched for gestational week, sex, and race. Because the matching involved only categorical factors, odds ratios (ORs) and 95% confidence intervals (CIs) were estimated using unconditional logistic regression analysis, allowing all study subjects to be included. I included race, sex, and gestational age as confounding variables in all analyses, as well as the following risk factors known to be associated with IUGR: weight gain during pregnancy, prepregnancy body mass index (BMI), parity, history of preeclampsia, prior history of IUGR, primiparity, and smoking during pregnancy. I also tested for gene-environment interactions, that is, whether the effect of water contaminants (total THMs and chloroform in tap water) was modified by newborn and maternal genetic variants (one or two variant alleles vs. none), using a heterogeneity chi-square test (Hills and De Stavola 2002).

Results

Table 1 provides some background maternal characteristics for cases and controls. As expected, case mothers had gained less weight during pregnancy and had a lower BMI before pregnancy. In addition, they were more likely to be older, to have smoked during the third trimester of pregnancy, to be primiparous, to have preeclampsia, and to report a previous pregnancy with IUGR.

Table 2 shows the distribution of exposure variables such as different THMs as well as showering and drinking-water habits. The only notable difference between cases and controls was the use of domestic water filters, which was higher among controls.

Table 3 shows the results for exposure to specific and total THMs in drinking water using the 90th percentile cutoff for average level of exposure. No increased risk was observed for any of the specific THMs or for total THMs. All reported ORs were fully adjusted. Using a cutoff at the 95th percentile (instead of the 90th) for average level of exposure, I estimated an OR of 1.17 (95% CI, 0.60-2.29) for chloroform and of 1.26 (95% CI, 0.65-2.45) for total THMs. I also estimated ORs for cumulative exposure to specific and total THMs in drinking water and found that results were very similar to those for average exposure (data not shown). Using the other indices for drinking water and the index for showering, I observed no increased risks (data not shown).

Table 4 shows the adjusted ORs for exposure to average levels of chloroform and total THMs from drinking water (contrasting the group above the 90th percentile with the group at or below the 90th), according to whether the newborn or the mother carried one or two variant alleles, as opposed to none. The risk of IUGR associated with exposure to total THMs was different between newborn carriers and noncarriers of the CYP2E1 variant. An increased risk was also observed among the newborn carriers for exposure to chloroform, as well as among mother carriers for both exposures (chloroform and total THMs), but the risks were not statistically different across the gene strata. I also observed statistical heterogeneity in the risk of IUGR between newborns carriers and noncarriers of the CYP2E1 variant for exposure to average levels of chloroform and total THMs measured as numerical variables (data not shown). No effect modification was observed when contrasting carriers and noncarriers of the T allele in the MTHFR C677T gene. No significant effect modification was observed between newborn or maternal carriers and noncarriers of either polymorphism when exposure was defined with the other indices for drinking water or for showering.

Discussion

My results for the association between exposure to water contaminants were largely negative, whether average or cumulative levels from drinking water at the tap were used or when I also accounted for drinking water and showering habits. There were some indications that, with increased genetic susceptibility, especially in the newborn, measured by the presence of a variant in the CYP2E1 gene, exposure to total THMs was associated with substantial risk. I know of no similar results.

The results from previous studies are mixed with respect to IUGR (often referred to as small for gestational age): Four studies reported associations (Bove et al. 1995; Gallagher et al. 1998; Kramer et al. 1992; Wright et al. 2003), and five did not (Dodds et al. 1999; Jaakkola et al. 2001; Kallen and Robert 2000; Savitz et al. 1995; Yang et al. 2000). In the present study, selection bias was unlikely. Exposure assessment at the personal level was more detailed than in most previous studies because I accounted for the use of bottled water as drinking water, the drinking habits, and the showering habits (although not the bathing habits). A substantial proportion of women were drinking only bottled water, which influenced the levels of exposure to THMs reported in the study. Despite these positive features, misclassification of exposure to water contaminants was most certainly present; in particular, better measures could be achieved if assigned levels were based on specific locations within the distribution systems when multiple locations within the system were sampled. Another advantage of this study, compared with many of the previous studies using birth records, was the extensive control for confounding; gestational age, child's sex, race, maternal smoking, primiparity, weight gain during pregnancy, BMI, previous IUGR, and pregnancy hypertension are all known risk factors for IUGR for which I was able to adjust.

Despite the absence of association between exposure to THMs and IUGR, the adverse effects of exposure of THMs were uncovered when taking into account genetic susceptibility. The study included subjects from many racial backgrounds; confounding by ethnicity, known as population stratification, can bias the results of case-control studies with genetic risk factors. However, I adjusted for race in all analyses. Other confounders for IUGR were measured and controlled for in the analysis.

The mechanism by which exposure to THMs affects fetal growth is not known; among humans, almost all studies have been epidemiologic, and therefore other types of studies addressing mechanisms are not available. A recent toxicologic study hypothesized that BDCM could disrupt the synthesis and/or secretion of placental syncytiotrophoblast-derived chorionic gonadotropin (Chen et al. 2003). The authors tested whether BDCM targets trophoblasts by examining the effect of BDCM on chorionic gonadotropin secretion by primary cultures of human trophoblasts. The results showed that BDCM reduced the secretion of immunoreactive and bioactive chorionic gonadotropin, and thus the component appears to target human placental trophoblasts. Trophoblasts are the sole source of chorionic gonadotropin during normal human pregnancy; thus, a decrease in the amount of this bioactive hormone could have adverse effects on pregnancy outcome. However, much more work is still needed to elucidate the possible effects on human fetal growth.

A few years ago, Chen et al. (1996) were the first to suggest that carriers of the common MTHFR C677T polymorphism could be at higher risk for the effects of chloroform in drinking water. MTHFR is involved in the metabolism of methionine and homocysteine through a mechanism that is vitamin [B.sub.12] dependent; as suggested by Alston (1991), the latter could be inhibited by chloroform. Among carriers of the T allele, in particular the homozygotes, the transformation of homocysteine to methionine is less efficient and possibly the exposure to chloroform could inhibit this transformation even more. In this study, I found no indication that MTHFR C677T will modify the effect of exposure to chloroform. It is likely that this is not a promising hypothesis after all, at least for fetal growth.

The tested variant in CYP2E1 is in the regulatory region and is associated with an increased transcriptional activity (Hayashi et al. 1991). The carriers would be expected to have an increased metabolism of THMs resulting in the production of activated metabolites. Our results are coherent with this hypothesis. This indication for gene-environment interaction should lead to more similar investigations because it is very unlikely that only one polymorphic gene is involved in the metabolism of THMs.

In conclusion, in the present study I was unable to show effects of exposure to THMs from DBPs on the risk of IUGR. However, among newborn carriers of a CYP2E1 gene variant, important effects were observed. These results will need confirmation. They also suggest that accounting for genetic susceptibility is a sensible way to study the effects of environmental exposures when there is information on the candidate genes involved in the metabolism of these agents.

Table 1. Distribution of maternal characteristics between cases
(n=493) and controls (n=472).

Characteristic                         Cases             Controls

Race [no. (%)]
  White                             330 (66.9)          333 (70.5)
  Black                             117 (23.7)          110 (23.3)
  Asian                              24 (4.8)            13 (2.7)
  Hispanic/Amerindian                22 (4.4)            16 (3.4)
Age [greater than or equal to]       86 (17.4)           70 (14.8)
  36 years [no. (%)]
Schooling [less than or             108 (21.9)           96 (20.3)
  equal to] 12 years [no. (%)]
Prepregnancy BMI                 22.8 [+ or -] 4.3   23.2 [+ or -] 5.2
  (mean [+ or -] SD)
Weight gain during pregnancy,    12.7 [+ or -] 5.5   14.4 [+ or -] 5.6
    kg (mean [+ or -] SD)
  Primiparous [no. (%)]             321 (65.2)          234 (49.6)
  Preeclampsia [no. (%)]             69 (14.0)           12 (2.5)
Previous IUGR among parous           66 (38.4)           23 (9.7)
  [no. (%)]
Any cigarette smoking in 3rd        112 (22.7)           72 (15.7)
  trimester [no. (%)]

Table 2. Distribution of exposure variables between cases and controls.

Variable                         Cases                 Controls

THM concentration
    ([micro]g/L)
    at the tap
    (mean [+ or -] SD)
  Chloroform              11.84 [+ or -] 18.19   11.58 [+ or -] 16.31
  Bromoform                0.42 [+ or -] 0.62     0.36 [+ or -] 0.65
  BDCM                     4.34 [+ or -] 2.94     4.24 [+ or -] 3.42
  Chlorodibromomethane     2.21 [+ or -] 1.95     2.08 [+ or -] 2.30
  Total THM               18.74 [+ or -] 19.76   18.26 [+ or -] 18.89
Other exposure
    characteristics
  Drinking bottled                21.9                   26.4
    water (%)
  Private well (%)                 0.66                   0.95
  Use of domestic water           14.7                    9.9
    filter at tap (%)
  Glasses of water/         6.8 [+ or -] 4.7       6.7 [+ or -] 4.2
    day (a) (mean
    [+ or -] SD)
  No. of weekly showers     6.8 [+ or -] 3.9       6.9 [+ or -] 3.8
    (mean [+ or -] SD)
  Duration of showers,     12.6 [+ or -] 8.3      13.1 [+ or -] 7.3
     min (mean [+ or -]
     SD)

(a) Includes water mixed with frozen juices.

Table 3. Adjusted (a) ORs (95% CIs) for IUGR in relation to exposure
to specific and total THMs in drinking water measured as average
levels at the tap.

                                   Value at cutoff
Exposure index                       ([micro]g/L)       OR (95% CI)

Average level (> 90th percentile
  vs. [less than or equal to]
  90th percentile)
Chloroform                               23.7        1.06 (0.63-1.79)
Bromoform                                 1.22       2.44 (0.19-31.10)
BDCM                                      6.3        0.84 (0.50-1.43)
Chlorodibromomethane                      3.9        0.62 (0.27-1.44)
Total THM                                29.4        0.97 (0.57-1.62)

(a) Adjusted for gestational age, sex, race, mother's weight gain
during pregnancy, prepregnancy BMI, smoking during the third
trimester, primiparity, preeclampsia in the current pregnancy,
and previous IUGR.

Table 4. Adjusted (a) ORs (95% CIs) for exposure to THMs (chloroform
and total THMs) in drinking water measured as average level at the
tap, according to newborn and maternal polymorphisms in the CYP2E1
and MTHFR genes.

Gene                         Cases (n)   Controls (n)

Newborns
  CYP2E1 *5(G1259C)
    Wild type                   385          375
    1 or 2 variant alleles       45           37
  MTHFR C677T
    Wild type                   239          212
    1 or 2 variant alleles      195          204
Mothers
  CYP2E1 *5 G1259C
    Wild type                   395          380
    1 or 2 variant alleles       57           39
  MTHFR C677T
    Wild type                   244          214
    1 or 2 variant alleles      212          206

                                         OR (95% CI) (b)

Gene                            Chloroform            Total THMs

Newborns
  CYP2E1 *5(G1259C)
    Wild type                0.99 (0.57-1.74)     0.82 (0.47-1.45)
    1 or 2 variant alleles   5.62 (0.82-38.39)   13.20 (1.19-146.72) *
  MTHFR C677T
    Wild type                1.78 (0.82-3.87)     1.63 (0.72-3.71)
    1 or 2 variant alleles   0.83 (0.38-1.54)     0.76 (0.38-1.54)
Mothers
  CYP2E1 *5 G1259C
    Wild type                0.88 (0.50-1.54)     0.83 (0.48-1.44)
    1 or 2 variant alleles   4.40 (0.73-26.42)    6.54 (0.59-71.45)
  MTHFR C677T
    Wild type                1.00 (0.46-2.18)     0.98 (0.46-2.10)
    1 or 2 variant alleles   1.12 (0.56-2.32)     0.94 (0.47-1.89)

(a) Adjusted for gestational age, sex, race, mother's weight gain
during pregnancy, prepregnancy BMI, smoking during the third
trimester, primiparity, preeclampsia in the current pregnancy, and
previous IUGR. (b) For exposure defined as a average level (> 90th
percentile vs. [less than or equal to] 90th percentile). * Chi-square
(1 degree of freedom) for effect modification =4 .87; p = 0.027.

REFERENCES

Alston TA. 1991. Inhibition of vitamin [B.sub.12]-dependent methionine biosynthesis by chloroform and carbon tetrachloride. Biochem Pharmacol 42:R25-R28.

Arbuckle TE, Wilkins R, Sherman GJ. 1993. Birth weight percentiles by gestational age in Canada. Obstet Gynecol 81:39-48.

Botto LD, Yang Q. 2000. 5,10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: a HUGE review. Am J Epidemiol 151:862-877.

Bove FJ, Fulcomer MC, Klotz JB, Esmart J, Dufficy EM, Savrin JE. 1995. Public drinking water contamination and birth outcome. Am J Epidemiol 141:850-852.

Bove F, Shim Y, Zeitz P. 2002. Drinking water contaminants and adverse pregnancy outcomes: a review. Environ Health Perspect 110(suppl 1):61-74.

Chen ATL, Reidy JA, Sever LE. 1996. Public drinking water contamination and birth outcomes [Letter]. Am J Epidemiol 143:1179-1180.

Chen J, Douglas GC, Thirkill TL, Lohstroh PN, Bielmeier SR, Narotsky MG, et al. 2003. Effect of bromodichloromethane on chorionic gonadotrophin secretion by human placental trophoblast cultures. Toxicol Sci 76:75-82.

Dodds L, King W, Woolcott C, Pole J. 1999. Trihalomethanes in public water supplies and adverse birth outcomes. Epidemiology 10:233-237.

Gallagher MD, Nuckols JR, Stallones L, Savitz DA. 1998. Exposure to trihalomethanes and adverse pregnancy outcomes. Epidemiology 9:484-489.

Geveker Graves C, Matanoski GM, Tardiff RG. 2001. Weight of evidence for an association between adverse reproductive and developmental effects and exposure to disinfection-by-products: a critical review. Reg Toxicol Pharmacol 34:103-124.

Hayashi SI, Watanabe J, Kawajiri K. 1991. Genetic polymorphisms in the 5' flanking region change transcriptional regulation of the human cytochrome P450E1 gene. J Biochem 110:559-565.

Hills M, De Stavola BL. 2002. A Short Introduction to STATA for Biostatistics. London:Timberlake Consultants Ltd.

Infante-Rivard C, Amre D, Sinnett D. 2002a. GSTT1 and CYP2E1 polymorphisms and trihalomethanes in drinking water: effect on childhood leukemia. Environ Health Perspect 110:591-593.

Infante-Rivard C, Levy E, Rivard GE, Guiguet M, Feoli-Fonseca JC. 2003a. Small babies receive the cardiovascular protective apolipoprotein [epsilon]2 allele less frequently than expected. J Med Gen 40:626-629.

Infante-Rivard C, Rivard GE, Gauthier R, Theoret Y. 2003b. Unexpected relation between plasma homocysteine and intrauterine growth restriction? Clin Chem 49:1476-1482.

Infante-Rivard C, Rivard GE, Yotov W, Genin E, Guiguet M, Weinberg C, et al. 2002b. Absence of association of thrombophilia polymorphisms with intrauterine growth retardation. N Engl J Med 347:19-24.

Jaakkola JJK, Magnus P, Skrondal A, Hwang BF, Becher G, Dybing E. 2001. Foetal growth and duration of gestation relative to water chlorination. Occup Environ Med 58:437-442.

Kallen BAJ, Robert E. 2000. Drinking water chlorination and delivery outcome--a registry-based study in Sweden. Reprod Toxicol 14:303-309.

Kramer MD, Lynch CF, Isacson P, Hanson JW. 1992. The association of waterborne chloroform with intrauterine growth retardation. Epidemiology 3:407-413.

Meek ME, Beauchamp H, Long G, Moir D, Turner L, Walker M. 2002. Chloroform: exposure estimation, hazard characterization, and exposure-response analysis. J Toxicol Environ Health 5(Part B):283-334.

Savitz DA, Andrews KW, Pastore LM. 1995. Drinking water and pregnancy outcome in central North Carolina: source, amount, and trihalomethane levels. Environ Health Perspect 103:592-596.

Wright JM, Schwartz J, Dockery DW. 2003. Effect of trihalomethane exposure on fetal development. Occup Environ Med 60:173-180.

Yang CH, Cheng BH, Tsai SS, Wu TN, Lin MC, Lin KC. 2000. Association between chlorination of drinking water and adverse pregnancy outcome in Taiwan. Environ Health Perspect 108:765-768.

Claire Infante-Rivard

Department of Epidemiology, Biostatistics and Occupational Health, Faculty of Medicine, McGill University, Montreal, Quebec, Canada

Address correspondence to C. Infante-Rivard, Department of Epidemiology, Biostatistics, and Occupational Health, Faculty of Medicine, McGill University, 1130 Pine Ave. West, Montreal, Quebec, Canada H3A 1A3. Telephone: [phone]. Fax: [phone]. E-mail: claire.infante-rivard@ mcgill.ca

This project was supported by grants from the Canadian Institutes of Health Research. The author holds a Canada Research Chair (James McGill Professorship).

The author declares she has no competing financial interests.

Received 5 February 2004; accepted 26 May 2004.